Vaccines
Cancer Vaccine Plus Interleukin-7 Boosts Immune Response to Cancer
Sunday, April 26 2009 13:00
Scientists have discovered that combining interleukin-7 (IL-7) – a key component of the immune system – with a viral vaccine improves the ability of the immune system to attack tumors. A Canadian team at The Campbell Family Institute for Breast Cancer Research (CFIBCR) at Princess Margaret Hospital, Toronto say their discovery could be included in new clinical trials that use a patient’s own cells to destroy tumors.
New Method of Teaching Immune System to Recognize A Prostate Cancer Marker, PSMA
Monday, April 20 2009 02:26
PSMA (prostate specific membrane antigen) is a marker expressed in advanced prostate cancer in many men including men with bone metastases. Several methods of exploiting it to target cells and prostate tumors are in clinical trials or under research. Prostate cancer patients in an ongoing Phase 1 study have been treated with designer T cells modified by retroviral gene therapy.
